MV Relling

2.1k total citations
14 papers, 1.5k citations indexed

About

MV Relling is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, MV Relling has authored 14 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 7 papers in Pediatrics, Perinatology and Child Health and 4 papers in Molecular Biology. Recurrent topics in MV Relling's work include Acute Lymphoblastic Leukemia research (11 papers), Childhood Cancer Survivors' Quality of Life (5 papers) and Acute Myeloid Leukemia Research (4 papers). MV Relling is often cited by papers focused on Acute Lymphoblastic Leukemia research (11 papers), Childhood Cancer Survivors' Quality of Life (5 papers) and Acute Myeloid Leukemia Research (4 papers). MV Relling collaborates with scholars based in United States, Netherlands and Japan. MV Relling's co-authors include WE Evans, C‐H Pui, GK Rivera, Jeffrey E. Rubnitz, RC Ribeiro, JT Sandlund, C-H Pui, J T Sandlund, Teri E. Klein and Dario Campana and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Leukemia and Journal of Paediatrics and Child Health.

In The Last Decade

MV Relling

14 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
MV Relling United States 12 884 725 363 329 253 14 1.5k
Shinji Kishi Japan 14 421 0.5× 323 0.4× 207 0.6× 310 0.9× 74 0.3× 55 967
Christine Hartford United States 22 459 0.5× 298 0.4× 684 1.9× 574 1.7× 48 0.2× 36 1.7k
Siebold S.N. de Graaf Netherlands 18 686 0.8× 276 0.4× 965 2.7× 536 1.6× 56 0.2× 38 1.6k
Jean‐Marie Leclerc Canada 18 231 0.3× 314 0.4× 139 0.4× 167 0.5× 19 0.1× 57 1.1k
José Luís Poveda Spain 18 159 0.2× 180 0.2× 160 0.4× 181 0.6× 78 0.3× 90 922
G H Reaman United States 13 503 0.6× 310 0.4× 378 1.0× 118 0.4× 16 0.1× 17 915
Asim Belgaumi Saudi Arabia 18 293 0.3× 244 0.3× 151 0.4× 248 0.8× 14 0.1× 63 959
A N Békássy Sweden 17 309 0.3× 209 0.3× 958 2.6× 239 0.7× 58 0.2× 31 1.4k
Kristen McCullough United States 16 103 0.1× 160 0.2× 300 0.8× 181 0.6× 204 0.8× 53 805
Marie‐Hélène Schlageter France 19 113 0.1× 431 0.6× 321 0.9× 342 1.0× 142 0.6× 39 1.4k

Countries citing papers authored by MV Relling

Since Specialization
Citations

This map shows the geographic impact of MV Relling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MV Relling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MV Relling more than expected).

Fields of papers citing papers by MV Relling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MV Relling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MV Relling. The network helps show where MV Relling may publish in the future.

Co-authorship network of co-authors of MV Relling

This figure shows the co-authorship network connecting the top 25 collaborators of MV Relling. A scholar is included among the top collaborators of MV Relling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MV Relling. MV Relling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Swen, JJ, et al.. (2017). Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group. Clinical Pharmacology & Therapeutics. 103(4). 599–618. 169 indexed citations
2.
Relling, MV, Teri E. Klein, Naohiro Terada, et al.. (2017). New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine. Clinical Pharmacology & Therapeutics. 102(6). 897–902. 25 indexed citations
3.
Pui, C-H, D Pei, J T Sandlund, et al.. (2009). Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia. 24(2). 371–382. 209 indexed citations
4.
Yang, Jun J., Cheng Chen, Xiangjun Cai, et al.. (2008). Etoposide Sensitivity Does Not Predict MLL Rearrangements or Risk of Therapy-Related Acute Myeloid Leukemia. Clinical Pharmacology & Therapeutics. 84(6). 691–697. 7 indexed citations
5.
6.
Shuster, JJ, FG Behm, Bruce M. Camitta, et al.. (2000). Glutathione S-transferase genotypes in children who develop treatment-related acute myeloid malignancies. Leukemia. 14(2). 232–237. 55 indexed citations
7.
Gajjar, Amar, et al.. (2000). Individualized methotrexate dosing in children with relapsed acute lymphoblastic leukemia. Leukemia. 14(2). 221–225. 64 indexed citations
8.
Pui, C‐H, GK Rivera, JT Sandlund, et al.. (2000). Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital. Leukemia. 14(12). 2286–2294. 156 indexed citations
9.
Rubnitz, Jeffrey E., F G Behm, David Wichlan, et al.. (1999). Low frequency of TEL-AML1 in relapsed acute lymphoblastic leukemia supports a favorable prognosis for this genetic subgroup. Leukemia. 13(1). 19–21. 68 indexed citations
10.
Rubnitz, Jeffrey E., MV Relling, JT Sandlund, et al.. (1998). Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemia. Leukemia. 12(8). 1176–1181. 83 indexed citations
11.
Storm, M, WE Evans, JT Sandlund, et al.. (1998). Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia. Leukemia. 12(10). 1527–1533. 103 indexed citations
12.
Pui, C‐H, MV Relling, RC Ribeiro, et al.. (1997). Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies. Leukemia. 11(11). 1813–1816. 134 indexed citations
13.
Rubnitz, Jeffrey E., FG Behm, C-H Pui, et al.. (1997). Genetic studies of childhood acute lymphoblastic leukemia with emphasis on p16, MLL, and ETV6 gene abnormalities: results of St Jude Total Therapy Study XII. Leukemia. 11(8). 1201–1206. 70 indexed citations
14.
Liu, Qi‐Jun, et al.. (1997). Cytochrome P450 2D6 and glutathione S‐transferase genotype in sudden infant death syndrome. Journal of Paediatrics and Child Health. 33(1). 31–37. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shinji Kishi Breakdown of academic impact, for papers by Christine Hartford Breakdown of academic impact, for papers by Siebold S.N. de Graaf Breakdown of academic impact, for papers by Jean‐Marie Leclerc Breakdown of academic impact, for papers by José Luís Poveda Breakdown of academic impact, for papers by G H Reaman Breakdown of academic impact, for papers by Asim Belgaumi Breakdown of academic impact, for papers by A N Békássy Breakdown of academic impact, for papers by Kristen McCullough Breakdown of academic impact, for papers by Marie‐Hélène Schlageter
Rankless by CCL
2026